MedTrace Logo

Study to Evaluate the Usability of PointCheck

NCT04448314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2023-08-22

No results posted yet for this study

Summary

This a study about the usability of PointCheck a novel non-invasive technology for monitoring chemotherapy-induced neutropenia. The study will include patients with cancer visiting the outpatient hematology clinic for their standard of care chemotherapy administration. A final sample size of 60 oncologic outpatients will be enrolled and studied with the technology.

The main objective is to evaluate the usability of PointCheck. Secondary outcomes include a preliminary assessment of PointCheck diagnostic accuracy and precision.

For this, study subjects will be tested twice with PointCheck during the same session and the usability in an at-home simulated environment by naïve users will be evaluated.

Conditions

  • Neoplasms
  • Chemotherapy-induced Neutropenia

Interventions

DIAGNOSTIC_TEST

PointCheck

This is a usability study on PointCheck, a new technology to detect chemotherapy-induced neutropenia

Sponsors & Collaborators

  • Leuko Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Joaquin Martinez López, MD · Fundación de Investigación del Hospital 12 de Octubre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-11
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04448314 on ClinicalTrials.gov